Hearing test definition

Hearing test means an evaluation of each of a newborn’s or an infant’s ears, using audiological equipment to:
Sample 1Sample 2Sample 3
Hearing test means an evaluation of both ears of a newborn or infant, using audiological equipment, for the pres- ence, type, or degree of hearing loss.
Sample 1Sample 2
Hearing test means an evaluation of each of a new- born’s or an infant’s ears, using audiological equipment to:
Sample 1

Examples of Hearing test in a sentence

  • Pass a pre-training medical examination as scheduled by the City: • Hearing test • All applicants must have a least 20/40 vision in each eye with correction and must be binocular and monocular of 20/100 vision in each eye without correction (glasses or contacts).

  • Diagnostic tests: 31231 – Nasal endoscopy 31575 – Flexible laryngoscope (endoscopy of the throat and voice box)31579 – Videostroboscopy (evaluation of vocal cord vibration) 92557 – Audiogram (Hearing test) 92567 – Tympanometry (Evaluation of Ear Drum compliance) 10021 – Fine Needle Aspiration (Needle Biopsy) 95922-allergy Smell test.

  • Hearing test or cost of hearing aids unless resulting form accidental injury.

  • Hearing test results from 53 members of the Vancouver Symphony Orchestra (VSO) were evaluated by the authors of this paper.

  • Politically, these nations are not an obvious group given the differences in their internal political structures.

  • Managers are required to consult with and provide information to workers exposed to hazardous noise – see Appendix A: Hearing test information.

  • Managing vision impairment15 Roles and responsibilities 16Definitions 17References 18Roads and Maritime references 18External references 18Appendices 19A Hearing test information 19B Vision testing information 20Document control 21Change history 21Feedback 21 Introduction‌Purpose‌Roads and Maritime undertakes a wide range of activities in diverse work environments and as a result Roads and Maritime workers1 may at times be exposed to physical hazards or hazardous substances.

  • Physical examination or screening being objected to: Vision test Hearing test Scoliosis test Other, please specify Comments: Name of student (Printed) Signature of parent (or student, if 18 or older) Date form was filed (To be filled in by office personnel)4.42—STUDENT HANDBOOK‌ It shall be the policy of the Salem School District that the most recently adopted version of the Student Handbook be incorporated by reference into the policies of this district.

  • The following tests shall also be carried out on the day: Eyesight test – An unaided eyesight test will be carried out on the day (glasses/lenses to be removed one hour prior to testing) Hearing test – air conduction audiogram (unaided i.e. testing without hearing aid) Urine testing for routine clinical screen Manual peak flow reading Blood pressure and pulse check Substance misuse testing may also form part of the process.

  • Hearing test was conducted three times from May 1996 to July 1998, at three wards in Chatan Town and Kadena Town, where WECPNL ranged from 85 to 95 and more.


More Definitions of Hearing test

Hearing test. (聽力測驗) means a hearing test designated by the Board under section 36;
Sample 1

Related to Hearing test

  • Screening Test means a drug or alcohol test which uses a method of analysis allowed by the Minnesota Drug and Alcohol Testing in the Workplace Act to be used for such purposes.

  • Hearing aid means an instrument or device designed for regular and constant use in or proximate to the human ear and represented as aiding or improving defective human hearing.

  • Hearing impairment means an impairment in hearing, whether permanent or fluctuating, that adversely affects the child's educational performance but that is not included under the definition of deafness in this section.

  • RDDS test Means one query sent to a particular “IP address” of one of the servers of one of the RDDS services. Queries shall be about existing objects in the Registry System and the responses must contain the corresponding information otherwise the query will be considered unanswered. Queries with an RTT 5 times higher than the corresponding SLR will be considered as unanswered. The possible results to an RDDS test are: a number in milliseconds corresponding to the RTT or undefined/unanswered.

  • COVID-19 test means a viral test for SARS-CoV-2 that is:

  • Phase II Study means a human clinical trial, for which the primary endpoints include a determination of dose ranges and/or a preliminary determination of efficacy in patients being studied as described in 21 C.F.R. § 312.21(b) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Drug test means a test designed to detect the illegal use of a controlled substance.

  • Commissioning test means tests applied to the Generating Facility, after completion of the construction of the Generating Facility, in order to verify that the Generating Facility may be released for Operation.

  • Permanency hearing means a hearing, conducted with respect to a child who is in foster care, to determine the permanency plan for the child which includes:

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Phase III Study means a human clinical trial that is prospectively designed to demonstrate statistically whether a product is safe and effective for use in humans in a manner sufficient to obtain regulatory approval to market such product in patients having the disease or condition being studied as described in 21 C.F.R. § 312.21(c) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Contested case hearing means a hearing under chapter 4 of the administrative procedures act of 1969, MCL 24.271 to 24.287, as authorized under chapter 5 of the administrative procedures act of 1969, MCL 24.291 to 24.292.

  • Start-Up Testing means the completion of applicable required factory and start-up tests as set forth in Exhibit C.

  • Remediation Period has the meaning specified in Section 8.2(a);

  • EPP test Means one EPP command sent to a particular “IP address” for one of the EPP servers. Query and transform commands, with the exception of “create”, shall be about existing objects in the Registry System. The response shall include appropriate data from the Registry System. The possible results to an EPP test are: a number in milliseconds corresponding to the “EPP command RTT” or undefined/unanswered.

  • Contract Transition Period means the 90 day transition as defined in Section F of this Contract.

  • DNS test Means one non-­‐recursive DNS query sent to a particular “IP address” (via UDP or TCP). If DNSSEC is offered in the queried DNS zone, for a query to be considered answered, the signatures must be positively verified against a corresponding DS record published in the parent zone or, if the parent is not signed, against a statically configured Trust Anchor. The answer to the query must contain the corresponding information from the Registry System, otherwise the query will be considered unanswered. A query with a “DNS resolution RTT” 5 times higher than the corresponding SLR, will be considered unanswered. The possible results to a DNS test are: a number in milliseconds corresponding to the “DNS resolution RTT” or, undefined/unanswered.

  • Hearing means an oral hearing and includes a hearing conducted in whole or in part by video link, telephone or other means of instantaneous two-way electronic communication;

  • Phase II Trial means a clinical trial of a Licensed Product on patients, including possibly pharmacokinetic and dose ranging studies, the principal purposes of which are to make a preliminary determination that such Licensed Product is safe for its intended use and to obtain sufficient information about such Licensed Product’s efficacy to permit the design of further clinical trials, and generally consistent with 21 CFR §312.21(b), or its successor regulation, or the equivalent in any foreign country.

  • Drug use test means a scientifically substantiated method to test for the presence of illegal or performance-enhancing drugs or the metabolites thereof in a person’s urine.

  • Covenant Testing Period means the period commencing on the last day of the fiscal month of Borrower most recently ended prior to the occurrence of a Fixed Charge Test Commencement Date for which month Borrowers have delivered to Agent monthly financial statements of Solutions and its Subsidiaries, and continuing until the Termination Date has occurred.

  • Examination Period as defined in Section 4.01.

  • Witness Test means the Company’s right to witness the commissioning testing and/or Company-required Interconnecting Customer-owned communication system. Commissioning testing is defined in IEEE Standard 1547-2003.

  • Phase 3 Trial means a human clinical trial of a Product on a sufficient number of subjects that is designed to establish that a pharmaceutical product is safe and efficacious for its intended use, and to determine warnings, precautions and adverse reactions that are associated with such pharmaceutical product in the dosage range to be prescribed, which trial is intended to support Approval of a Product, as described in 21 C.F.R. 312.21(c) for the United States, or a similar clinical study prescribed by the Regulatory Authorities in a foreign country.

  • Pivotal Clinical Trial means a pivotal human clinical trial of a Licensed Product with a defined dose or a set of defined doses of such Licensed Product designed to ascertain efficacy and safety of such Licensed Product for the purpose of enabling the preparation and submission of an MAA to the competent Regulatory Authorities in a country of the Territory, as further defined in 21 C.F.R. § 312.21(c) for the U.S., as amended from time to time, or the corresponding foreign regulations.

  • Phase III Trial means a human Clinical Trial of the Licensed Product, which trial is designed (a) to establish that the Licensed Product is safe and efficacious for its intended use; (b) to define warnings, precautions and adverse reactions that are associated with the Licensed Product in the dosage range to be prescribed; and (c) consistent with 21 CFR § 312.21(c).